THE CHALLENGE
When the body and mind begin to decline
Across many serious diseases, people lose the functions that make independence possible.
For patients and families, these conditions are not abstract diagnoses. They mean the loss of abilities that shape identity, autonomy, and quality of life.
Alzheimer’s Disease
A progressive neurodegenerative disease that erodes memory, identity, and independence.
Strength
Cancer-related cachexia causes severe muscle and weight loss that can leave patients weaker during treatment and recovery.
Resilience
Age-related muscle loss contributes to frailty, reduced mobility, instability, and loss of everyday function.
our science
Science backed by translational research
Recall’s work is grounded in genetic studies, preclinical research, and emerging biological insights that connect cognitive decline with systemic health.
By targeting pathways that influence both brain and body, we are exploring new therapeutic strategies aimed at restoring functions that disease and aging gradually take away.
AREAS OF FOCUS
Where restoring function could matter most
Our research currently centers on three areas where restoring lost function could have meaningful clinical impact.
leadership
Experienced leadership. Purpose-driven science
Recall brings together biotechnology leaders, physician-scientists, and Alzheimer’s experts with a shared goal: restoring the functions disease and aging take away.
Dan Salain
CEO & Co-Founder
Biotechnology executive with experience building venture-backed life sciences companies and advancing innovative therapies from development through commercialization.
Atul Chopra, MD, PhD
CSO & Co-Founder
Physician-scientist, medical geneticist and serial founder focused on the biological pathways connecting neurological disease, systemic decline, and aging.
Meet the Team and Advisors
NEWS & UPDATES
Follow the latest from Recall Therapeutics
Announcements, research updates, and company developments.
